Tinea Faciei in Children: A Case Series at the Instituto Nacional de Salud del Niño-Breña (Lima-Peru)

Medina_Flores Juan; Gonzales_Saravia Carlos

doi:doi:10.11648/j.cmr.20221103.15

| Peer-Reviewed

Tinea Faciei in Children: A Case Series at the Instituto Nacional de Salud del Niño-Breña (Lima-Peru)

Medina_Flores Juan, Gonzales_Saravia Carlos

Published in Clinical Medicine Research (Volume 11, Issue 3)

Received: 10 February 2022 Accepted: 11 March 2022 Published: 14 June 2022

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

The objective of this study is to report the epidemiology, clinical and microbiological characteristics, and treatment of pediatric patients diagnosed with tinea faciei. 30 cases have been identified in which the infectious agent was isolated, the data was collected in statistical tables that were evaluated. In this series of cases, it is evidenced that tinea faciei affects more frequently the female sex in 73.3% and children under 5 years old in 66.6%. They attended with a time of disease greater than 30 days. 40% had previous treatment, 53.3% with polyvalent, topical corticoid and antibiotics. The presence of cats, dogs and rabbits was reported in 46% of cases, 76.7% had the genian region compromised. Trichophyton tonsurans was identified in 80% of cases and good response to topical treatment with terbinafine or sertaconazole in 100% of cases. The isolated etiological agents differ according to the geographical area where the study is carried out and new agents are reported that must be known given the wide interconnectivity between different geographical areas as well as the predisposing factors in the pediatric population that to date have not been clearly defined. These data must be proved with larger studies that allow to recognize patients that come to their medical appointment with this pathology. Tinea facie should have a CID-10 that identifies it, in order to have information from different geographical areas, since the isolation of new agents whose sensitivity to antifungals in use is necessary to know is reported. Finally, it is necessary to beware to new forms of clinical presentation due to the use of masks by COVID-19.

Published in	Clinical Medicine Research (Volume 11, Issue 3)
DOI	10.11648/j.cmr.20221103.15
Page(s)	70-73
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Pediatric, Tinea Faciei, Dermatology

References

[1]	Agarwal A, Hassanandani T, Das A, Panda M, Chakravorty S. 'Mask tinea': tinea faciei possibly potentiated by prolonged mask usage during the COVID-19 pandemic. Clin Exp Dermatol. 2021 Jan. 46 (1): 190-193.
[2]	Alkeswani A, Duncan JR, Theos A. Tinea faciei starting at day two of life. Pediatr Dermatol. 2019 Jan. 36 (1): e20-e22. [Medline].
[3]	Amigo M; Milani-Nejad N; Mosser-Goldfarb, Joy. Periocular Tinea Faciei. The Journal of Pediatrics, 2020, vol. 221, p. 255-256.
[4]	Ansari S, Ahmadi B, Tabatabaeifar SN, Hedayati MT, Javidnia J, Taghizadeh Armaki M, et al. Familial Cases of Trichophyton benhamiae Infection Transmitted from a Guinea Pig in Iran. Mycopathologia. 2021 Mar. 186 (1): 119-125. [Medline].
[5]	Borges A, et al. Tinea faciei in a central Portuguese hospital: A 9-year survey. Mycoses, 2018, vol. 61, no 4, p. 283-285.
[6]	GM Sangameshwara, U Venkatesh. Clinical study of cutaneous infection in children: Changing trends. Indian Journal of Paediatric Dermatology, Year 2015, Volume 16, Issue 3 [p. 136-138].
[7]	Lari AR, Akhlaghi L, Falahati M, Alaghehbandan R. Characteristics of dermatophytoses among children in an area south of Tehran, Iran. Mycoses. 2005. 48: 32-37. [Medline].
[8]	Meymandi S, Wiseman MC, Crawford RI. Tinea faciei mimicking cutaneous lupus erythematosus: a histopathologic case report. J Am Acad Dermatol. 2003 Feb. 48 (2 Suppl): S7-8. [Medline].
[9]	Patel G, Mills C. Tinea faciei due to Microsporum canis abscess formation. Clin Exp Dermatol. 2000 Nov. 25 (8): 608-10. [Medline].
[10]	Pragya K, et al. Clinical manifestations and diagnostic challenges of tinea faciei. Int J Curr Microbiol Applied, 2017, vol. 6, p. 1286-94.
[11]	Salimbeni L, Delfino C. Tinea faciei incognito. G Ital Dermatol Venereol. 2017 Aug. 152 (4): 390-391. [Medline].
[12]	Shital Poojary, Saurabh Jaiswal, Krishna B Bhalala, Jimish Bagadia, Kapisha S Shah, Suby Arora, Yesha Ruchir Patel, Pawan Gupta, Khanda S Khot, Ashish Rai, Mamta Dhayal. A cross sectional observational study of pediatric d Indian Journal of Paediatric Dermatology ermatophytosis: Changing clinico mycological patterns in Western India. Indian Journal of Paediatric Dermatology. Year: 2021 \| Volume: 22 \| Issue: 3 \| Page: 236-240.
[13]	Schwartz, MD, MPH; Chief Editor: Dirk M Elston Updated: Apr 09, 2021.
[14]	Sneha Gandhi, Suma Patil, Somnath Patil, Ambresh Badad. Clinicoepidemiological study of dermatophyte infections in pediatric age group at a tertiary hospital in Karnataka. Year: Indian Journal of Paediatric Dermatology 2019 \| Volume: 20 \| Issue: 1 \| Page: 52-56.
[15]	State-of-the-Art Dermatophyte Infections: Epidemiology Aspects, Pathophysiology, and Resistance Mechanisms Nilce M. Martinez-Rossi, Nalu T. A. Peres, Tamires A. Bitencourt, Maíra P. Martins J. Fungi 2021, 7, 629.
[16]	Tan J, Liu X, Gao Z, Yang H, Yang L, Wen H. A case of Tinea Faciei caused by Trichophyton benhamiae: first report in China. BMC Infect Dis. 2020 Feb 22. 20 (1): 171. [Medline].

Cite This Article

Plain Text BibTeX RIS

APA Style

Medina_Flores Juan, Gonzales_Saravia Carlos. (2022). Tinea Faciei in Children: A Case Series at the Instituto Nacional de Salud del Niño-Breña (Lima-Peru). Clinical Medicine Research, 11(3), 70-73. https://doi.org/10.11648/j.cmr.20221103.15

Copy | Download

ACS Style

Medina_Flores Juan; Gonzales_Saravia Carlos. Tinea Faciei in Children: A Case Series at the Instituto Nacional de Salud del Niño-Breña (Lima-Peru). Clin. Med. Res. 2022, 11(3), 70-73. doi: 10.11648/j.cmr.20221103.15

Copy | Download

AMA Style

Medina_Flores Juan, Gonzales_Saravia Carlos. Tinea Faciei in Children: A Case Series at the Instituto Nacional de Salud del Niño-Breña (Lima-Peru). Clin Med Res. 2022;11(3):70-73. doi: 10.11648/j.cmr.20221103.15

Copy | Download

@article{10.11648/j.cmr.20221103.15,
  author = {Medina_Flores Juan and Gonzales_Saravia Carlos},
  title = {Tinea Faciei in Children: A Case Series at the Instituto Nacional de Salud del Niño-Breña (Lima-Peru)},
  journal = {Clinical Medicine Research},
  volume = {11},
  number = {3},
  pages = {70-73},
  doi = {10.11648/j.cmr.20221103.15},
  url = {https://doi.org/10.11648/j.cmr.20221103.15},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cmr.20221103.15},
  abstract = {The objective of this study is to report the epidemiology, clinical and microbiological characteristics, and treatment of pediatric patients diagnosed with tinea faciei. 30 cases have been identified in which the infectious agent was isolated, the data was collected in statistical tables that were evaluated. In this series of cases, it is evidenced that tinea faciei affects more frequently the female sex in 73.3% and children under 5 years old in 66.6%. They attended with a time of disease greater than 30 days. 40% had previous treatment, 53.3% with polyvalent, topical corticoid and antibiotics. The presence of cats, dogs and rabbits was reported in 46% of cases, 76.7% had the genian region compromised. Trichophyton tonsurans was identified in 80% of cases and good response to topical treatment with terbinafine or sertaconazole in 100% of cases. The isolated etiological agents differ according to the geographical area where the study is carried out and new agents are reported that must be known given the wide interconnectivity between different geographical areas as well as the predisposing factors in the pediatric population that to date have not been clearly defined. These data must be proved with larger studies that allow to recognize patients that come to their medical appointment with this pathology. Tinea facie should have a CID-10 that identifies it, in order to have information from different geographical areas, since the isolation of new agents whose sensitivity to antifungals in use is necessary to know is reported. Finally, it is necessary to beware to new forms of clinical presentation due to the use of masks by COVID-19.},
 year = {2022}
}

Copy | Download

TY - JOUR
T1 - Tinea Faciei in Children: A Case Series at the Instituto Nacional de Salud del Niño-Breña (Lima-Peru)
AU - Medina_Flores Juan
AU - Gonzales_Saravia Carlos
Y1 - 2022/06/14
PY - 2022
N1 - https://doi.org/10.11648/j.cmr.20221103.15
DO - 10.11648/j.cmr.20221103.15
T2 - Clinical Medicine Research
JF - Clinical Medicine Research
JO - Clinical Medicine Research
SP - 70
EP - 73
PB - Science Publishing Group
SN - 2326-9057
UR - https://doi.org/10.11648/j.cmr.20221103.15
AB - The objective of this study is to report the epidemiology, clinical and microbiological characteristics, and treatment of pediatric patients diagnosed with tinea faciei. 30 cases have been identified in which the infectious agent was isolated, the data was collected in statistical tables that were evaluated. In this series of cases, it is evidenced that tinea faciei affects more frequently the female sex in 73.3% and children under 5 years old in 66.6%. They attended with a time of disease greater than 30 days. 40% had previous treatment, 53.3% with polyvalent, topical corticoid and antibiotics. The presence of cats, dogs and rabbits was reported in 46% of cases, 76.7% had the genian region compromised. Trichophyton tonsurans was identified in 80% of cases and good response to topical treatment with terbinafine or sertaconazole in 100% of cases. The isolated etiological agents differ according to the geographical area where the study is carried out and new agents are reported that must be known given the wide interconnectivity between different geographical areas as well as the predisposing factors in the pediatric population that to date have not been clearly defined. These data must be proved with larger studies that allow to recognize patients that come to their medical appointment with this pathology. Tinea facie should have a CID-10 that identifies it, in order to have information from different geographical areas, since the isolation of new agents whose sensitivity to antifungals in use is necessary to know is reported. Finally, it is necessary to beware to new forms of clinical presentation due to the use of masks by COVID-19.
VL - 11
IS - 3
ER -

Copy | Download

Author Information

Medina_Flores Juan

National Institute of Child Health, Universidad Nacional Mayor de San Marcos, Lima, Perú
Gonzales_Saravia Carlos

National Institute of Child Health, Universidad Nacional Mayor de San Marcos, Lima, Perú

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Medina_Flores Juan, Gonzales_Saravia Carlos. (2022). Tinea Faciei in Children: A Case Series at the Instituto Nacional de Salud del Niño-Breña (Lima-Peru). Clinical Medicine Research, 11(3), 70-73. https://doi.org/10.11648/j.cmr.20221103.15

Copy | Download

ACS Style

Medina_Flores Juan; Gonzales_Saravia Carlos. Tinea Faciei in Children: A Case Series at the Instituto Nacional de Salud del Niño-Breña (Lima-Peru). Clin. Med. Res. 2022, 11(3), 70-73. doi: 10.11648/j.cmr.20221103.15

Copy | Download

AMA Style

Medina_Flores Juan, Gonzales_Saravia Carlos. Tinea Faciei in Children: A Case Series at the Instituto Nacional de Salud del Niño-Breña (Lima-Peru). Clin Med Res. 2022;11(3):70-73. doi: 10.11648/j.cmr.20221103.15

Copy | Download

@article{10.11648/j.cmr.20221103.15,
  author = {Medina_Flores Juan and Gonzales_Saravia Carlos},
  title = {Tinea Faciei in Children: A Case Series at the Instituto Nacional de Salud del Niño-Breña (Lima-Peru)},
  journal = {Clinical Medicine Research},
  volume = {11},
  number = {3},
  pages = {70-73},
  doi = {10.11648/j.cmr.20221103.15},
  url = {https://doi.org/10.11648/j.cmr.20221103.15},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cmr.20221103.15},
  abstract = {The objective of this study is to report the epidemiology, clinical and microbiological characteristics, and treatment of pediatric patients diagnosed with tinea faciei. 30 cases have been identified in which the infectious agent was isolated, the data was collected in statistical tables that were evaluated. In this series of cases, it is evidenced that tinea faciei affects more frequently the female sex in 73.3% and children under 5 years old in 66.6%. They attended with a time of disease greater than 30 days. 40% had previous treatment, 53.3% with polyvalent, topical corticoid and antibiotics. The presence of cats, dogs and rabbits was reported in 46% of cases, 76.7% had the genian region compromised. Trichophyton tonsurans was identified in 80% of cases and good response to topical treatment with terbinafine or sertaconazole in 100% of cases. The isolated etiological agents differ according to the geographical area where the study is carried out and new agents are reported that must be known given the wide interconnectivity between different geographical areas as well as the predisposing factors in the pediatric population that to date have not been clearly defined. These data must be proved with larger studies that allow to recognize patients that come to their medical appointment with this pathology. Tinea facie should have a CID-10 that identifies it, in order to have information from different geographical areas, since the isolation of new agents whose sensitivity to antifungals in use is necessary to know is reported. Finally, it is necessary to beware to new forms of clinical presentation due to the use of masks by COVID-19.},
 year = {2022}
}

Copy | Download